{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:26:07Z","timestamp":1756189567546,"version":"3.41.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastric cancer (GC), a malignant neoplasm that arises from the epithelium of the gastric mucosa, endangers patients\u2019 lives and health severely. Regulator of G-protein signaling 16 (RGS16) has been found to be correlated with the malignant progression of various cancers, and BHLHE40 is highly expressed in GC. However, it remains unclear whether there is a regulatory mechanism between the them.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The bioinformatics tools were applied to assess the differentially expressed genes in GC. Next, the expression levels of mRNA and protein were evaluated by qRT-PCR and Western blot. Cellular behaviors were assessed using CCK-8, EdU, Transwell, and flow cytometry assays. Meanwhile, the ferroptosis-related indicators were measured. Subsequently, the xenograft models were set up to estimate the role of RGS16 in vivo. Besides, the interaction between BHLHE40 and RGS16 was determined using ChIP assay and dual-luciferase reporter assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>RGS16 exhibited an upregulated pattern in GC. In addition, silencing RGS16 impeded the proliferation, migration and invasion of GC cells while reinforcing apoptosis and ferroptosis. Moreover, RGS16 boosted the growth of tumors in vivo. Furthermore, BHLHE40 could bind to RGS16 and positively regulate its expression. Overexpression of RGS16 reversed the effects of silencing BHLHE40 on GC cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>BHLHE40 curbed ferroptosis and oxidative stress of GC cells by modulating the expression of RGS16, thereby facilitating the malignant progression of GC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00447-y","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:53:44Z","timestamp":1748062424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BHLHE40-mediated RGS16 upregulation: a driver propelling gastric cancer progression via ferroptosis suppression"],"prefix":"10.1186","volume":"162","author":[{"given":"Caiyun","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maifang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"447_CR1","doi-asserted-by":"crossref","unstructured":"Machlowska J, Baj J. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.","DOI":"10.3390\/ijms21114012"},{"issue":"3","key":"447_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"447_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"447_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"447_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Reviews Clin Oncol. 2023;20(5):338\u201349.","journal-title":"Nat Reviews Clin Oncol"},{"key":"447_CR6","doi-asserted-by":"crossref","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u20137:18\u201324.","DOI":"10.1016\/j.cancergen.2024.06.002"},{"issue":"1","key":"447_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discovery. 2021;7(1):193.","journal-title":"Cell Death Discovery"},{"key":"447_CR8","doi-asserted-by":"publisher","first-page":"104463","DOI":"10.1016\/j.pdpdt.2024.104463","volume":"51","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Ferroptosis: a novel cell death modality as a synergistic therapeutic strategy with photodynamic therapy. Photodiagn Photodyn Ther. 2025;51:104463.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"1","key":"447_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Therapy. 2024;9(1):55.","journal-title":"Signal Transduct Target Therapy"},{"issue":"7","key":"447_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Ferroptosis as a potential target for cancer therapy. Cell Death Dis. 2023;14(7):460.","journal-title":"Cell Death Dis"},{"issue":"1","key":"447_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","volume":"17","author":"Z Fatemeh-Jalali","year":"2024","unstructured":"Fatemeh-Jalali Z, et al. Ferroptosis inducers as promising radiosensitizer agents in cancer radiotherapy. Curr Radiopharmaceuticals. 2024;17(1):14\u201329.","journal-title":"Curr Radiopharmaceuticals"},{"issue":"1","key":"447_CR12","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1038\/s41467-023-39901-8","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang Z, et al. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nat Commun. 2023;14(1):4193.","journal-title":"Nat Commun"},{"key":"447_CR13","doi-asserted-by":"crossref","unstructured":"Le J et al. Targeting ferroptosis in gastric cancer: strategies and opportunities. Immunol Rev. 2024;321(1):228\u201345.","DOI":"10.1111\/imr.13280"},{"key":"447_CR14","doi-asserted-by":"crossref","unstructured":"Li D et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42(2):83\u201398.","DOI":"10.1038\/s41388-022-02537-x"},{"key":"447_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cancergen.2023.03.002","volume":"274\u2013275","author":"H Liu","year":"2023","unstructured":"Liu H. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma. Cancer Genet. 2023;274\u2013275:21\u20135.","journal-title":"Cancer Genet"},{"key":"447_CR16","doi-asserted-by":"publisher","first-page":"952290","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290.","journal-title":"Front Oncol"},{"issue":"8","key":"447_CR17","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J Cancer Res"},{"key":"447_CR18","doi-asserted-by":"crossref","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u20139:91\u2013103.","DOI":"10.1016\/j.cancergen.2023.10.001"},{"issue":"3","key":"447_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25(3):404\u201314.","journal-title":"Nat Cell Biol"},{"key":"447_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2015.03.002","volume":"133","author":"A Stewart","year":"2015","unstructured":"Stewart A, Fisher RA. Introduction: G protein-coupled receptors and RGS proteins. Prog Mol Biol Transl Sci. 2015;133:1\u201311.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"2","key":"447_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cell.2020.08.052","volume":"183","author":"I Masuho","year":"2020","unstructured":"Masuho I, et al. A global map of G protein signaling regulation by RGS proteins. Cell. 2020;183(2):503\u201321.e19.","journal-title":"Cell"},{"key":"447_CR22","doi-asserted-by":"publisher","first-page":"962321","DOI":"10.3389\/fmolb.2022.962321","volume":"9","author":"M Tian","year":"2022","unstructured":"Tian M, et al. Functions of regulators of G protein signaling 16 in immunity, inflammation, and other diseases. Front Mol Biosci. 2022;9:962321.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"447_CR23","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.molmet.2016.08.010","volume":"5","author":"K Vivot","year":"2016","unstructured":"Vivot K, et al. The regulator of G-protein signaling RGS16 promotes insulin secretion and \u03b2-cell proliferation in rodent and human islets. Mol Metab. 2016;5(10):988\u201396.","journal-title":"Mol Metab"},{"key":"447_CR24","doi-asserted-by":"crossref","unstructured":"Ruoyu H et al. RGS16 promotes glioma progression and serves as a prognostic factor. CNS Neurosci Ther. 2020;26(8):791\u2013803.","DOI":"10.1111\/cns.13382"},{"key":"447_CR25","doi-asserted-by":"crossref","unstructured":"Yanzhou Z et al. RGS16 regulates Hippo-YAP activity to promote esophageal cancer cell proliferation and migration. Biochem Biophys Res Commun. 2023;675:122\u20139.","DOI":"10.1016\/j.bbrc.2023.04.033"},{"issue":"2","key":"447_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/bbrc.1997.6960","volume":"236","author":"M Shen","year":"1997","unstructured":"Shen M, et al. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem Biophys Res Commun. 1997;236(2):294\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"447_CR27","doi-asserted-by":"crossref","unstructured":"Wang J et al. Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration. J Clin Lab Anal. 2022;36(7):e24539.","DOI":"10.1002\/jcla.24539"},{"issue":"1\u20132","key":"447_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18632\/genesandcancer.201","volume":"11","author":"Z Kiss","year":"2020","unstructured":"Kiss Z, Mudryj M, Ghosh PM. Non-circadian aspects of BHLHE40 cellular function in cancer. Genes Cancer. 2020;11(1\u20132):1\u201319.","journal-title":"Genes Cancer"},{"key":"447_CR29","doi-asserted-by":"crossref","unstructured":"Yan Z et al. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer. OMICS. 2009;13(4):301\u20136.","DOI":"10.1089\/omi.2009.0014"},{"key":"447_CR30","doi-asserted-by":"publisher","first-page":"107558","DOI":"10.1016\/j.pharmthera.2020.107558","volume":"212","author":"H Liu","year":"2020","unstructured":"Liu H, Dilger JP, Lin J. Effects of local anesthetics on cancer cells. Pharmacol Ther. 2020;212:107558.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"447_CR31","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","volume":"11","author":"LT Li","year":"2015","unstructured":"Li LT, et al. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep. 2015;11(3):1566\u201372.","journal-title":"Mol Med Rep"},{"issue":"16","key":"447_CR32","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang WJ, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452\u201368.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"447_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4240\/wjgs.v6.i4.55","volume":"6","author":"I Proserpio","year":"2014","unstructured":"Proserpio I, et al. Multimodal treatment of gastric cancer. World J Gastrointest Surg. 2014;6(4):55\u20138.","journal-title":"World J Gastrointest Surg"},{"key":"447_CR34","doi-asserted-by":"crossref","unstructured":"Li K et al. Advances in clinical immunotherapy for gastric cancer. Biochimica et biophysica acta (BBA) - Reviews on Cancer. 2021;1876(2):188615.","DOI":"10.1016\/j.bbcan.2021.188615"},{"issue":"1","key":"447_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"447_CR36","first-page":"23","volume":"24","author":"XY Qin","year":"2021","unstructured":"Qin XY. Research progression in clinical treatment of gastric cancer in 2020. Zhonghua Wei Chang Wai Ke Za Zhi. 2021;24(1):23\u20136.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"447_CR37","doi-asserted-by":"crossref","unstructured":"Huang R et al. RGS16 promotes glioma progression and serves as a prognostic factor. CNS Neurosci Ther. 2020;26(8):791\u2013803.","DOI":"10.1111\/cns.13382"},{"issue":"11\u201312","key":"447_CR38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.18632\/genesandcancer.43","volume":"5","author":"MB Carper","year":"2014","unstructured":"Carper MB, et al. RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells. Genes Cancer. 2014;5(11\u201312):420\u201335.","journal-title":"Genes Cancer"},{"key":"447_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbrc.2023.04.033","volume":"675","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. RGS16 regulates Hippo-YAP activity to promote esophageal cancer cell proliferation and migration. Biochem Biophys Res Commun. 2023;675:122\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"447_CR40","doi-asserted-by":"crossref","unstructured":"Shen H et al. Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-tables 2-TAK1-JNK\/p38 MAPK signaling. Cell Death Dis. 2024;15(6):438.","DOI":"10.1038\/s41419-024-06803-6"},{"issue":"32","key":"447_CR41","doi-asserted-by":"publisher","first-page":"21719","DOI":"10.1074\/jbc.M109.028407","volume":"284","author":"G Liang","year":"2009","unstructured":"Liang G, et al. RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling. J Biol Chem. 2009;284(32):21719\u201327.","journal-title":"J Biol Chem"},{"issue":"7","key":"447_CR42","doi-asserted-by":"publisher","first-page":"e36981","DOI":"10.1097\/MD.0000000000036981","volume":"103","author":"L Wenbo","year":"2024","unstructured":"Wenbo L, et al. Status and trends of RGS16 based on data visualization analysis: a review. Med (Baltim). 2024;103(7):e36981.","journal-title":"Med (Baltim)"},{"issue":"12","key":"447_CR43","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1245\/s10434-009-0690-3","volume":"16","author":"N Miyoshi","year":"2009","unstructured":"Miyoshi N, et al. RGS16 is a marker for prognosis in colorectal cancer. Ann Surg Oncol. 2009;16(12):3507\u201314.","journal-title":"Ann Surg Oncol"},{"key":"447_CR44","doi-asserted-by":"publisher","first-page":"112203","DOI":"10.1016\/j.intimp.2024.112203","volume":"134","author":"T Zhang","year":"2024","unstructured":"Zhang T, et al. Ferroptosis in antitumor therapy: unraveling regulatory mechanisms and immunogenic potential. Int Immunopharmacol. 2024;134:112203.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"447_CR45","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.it.2020.09.002","volume":"41","author":"ME Cook","year":"2020","unstructured":"Cook ME, et al. Transcription factor Bhlhe40 in immunity and autoimmunity. Trends Immunol. 2020;41(11):1023\u201336.","journal-title":"Trends Immunol"},{"key":"447_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2018.03.014","volume":"198","author":"A Camponeschi","year":"2018","unstructured":"Camponeschi A, et al. DEC1\/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells. Immunol Lett. 2018;198:7\u201311.","journal-title":"Immunol Lett"},{"key":"447_CR47","doi-asserted-by":"crossref","unstructured":"Yu F, Sharma S, Jankovic D. The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination. J Exp Med. 2018;215(7):1813\u201321.","DOI":"10.1084\/jem.20170155"},{"issue":"3","key":"447_CR48","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s13277-013-0697-z","volume":"34","author":"Y Liu","year":"2013","unstructured":"Liu Y, et al. The transcription factor DEC1 (BHLHE40\/STRA13\/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells. Tumour Biol. 2013;34(3):1641\u201350.","journal-title":"Tumour Biol"},{"issue":"1","key":"447_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tox.2012.06.022","volume":"301","author":"Y Peng","year":"2012","unstructured":"Peng Y, et al. Down regulation of differentiated embryonic chondrocytes 1 (DEC1) is involved in 8-methoxypsoralen-induced apoptosis in HepG2 cells. Toxicology. 2012;301(1):58\u201365.","journal-title":"Toxicology"},{"issue":"7735","key":"447_CR50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564(7735):268\u201372.","journal-title":"Nature"},{"issue":"5","key":"447_CR51","doi-asserted-by":"publisher","first-page":"e011273","DOI":"10.1161\/JAHA.118.011273","volume":"8","author":"KR Hernandez","year":"2019","unstructured":"Hernandez KR, et al. Regulator of G-protein signaling 16 is a negative modulator of platelet function and thrombosis. J Am Heart Assoc. 2019;8(5):e011273.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"447_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/omi.2009.0014","volume":"13","author":"Y Zheng","year":"2009","unstructured":"Zheng Y, et al. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer. OMICS. 2009;13(4):301\u20136.","journal-title":"OMICS"},{"key":"447_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1746-1596-8-37","volume":"8","author":"Y Jia","year":"2013","unstructured":"Jia Y, et al. Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1\u03b1 and Ki67 in human gastric cancer. Diagn Pathol. 2013;8:37.","journal-title":"Diagn Pathol"},{"key":"447_CR54","doi-asserted-by":"crossref","unstructured":"Zsofia K, Maria M, Paramita G. M, Non-circadian aspects of BHLHE40 cellular function in cancer. Genes Cancer. 2020;11(1-2):1\u201319.","DOI":"10.18632\/genesandcancer.201"},{"key":"447_CR55","doi-asserted-by":"crossref","unstructured":"Liu H, Dilger JP, Lin J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacology & Therapeutics. 2022;240:108302.","DOI":"10.1016\/j.pharmthera.2022.108302"},{"key":"447_CR56","doi-asserted-by":"publisher","first-page":"858756","DOI":"10.3389\/fonc.2022.858756","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J. A pan-cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front Oncol. 2022;12:858756.","journal-title":"Front Oncol"},{"issue":"1","key":"447_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-024-00620-x","volume":"12","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J. Voltage-gated sodium channels in cancers. Biomark Res. 2024;12(1):70.","journal-title":"Biomark Res"},{"key":"447_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2024.09.001","volume":"288\u2013289","author":"L Jahangiri","year":"2024","unstructured":"Jahangiri L. Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment. Cancer Genet. 2024;288\u2013289:32\u20139.","journal-title":"Cancer Genet"},{"key":"447_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cancergen.2023.12.002","volume":"280\u2013281","author":"H Ohyama","year":"2024","unstructured":"Ohyama H, et al. Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing. Cancer Genet. 2024;280\u2013281:6\u201312.","journal-title":"Cancer Genet"},{"key":"447_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2023.12.003","volume":"282\u2013283","author":"T Gonzalez","year":"2024","unstructured":"Gonzalez T, et al. Methylation signatures as biomarkers for non-invasive early detection of breast cancer: a systematic review of the literature. Cancer Genet. 2024;282\u2013283:1\u20138.","journal-title":"Cancer Genet"},{"issue":"13Supplement","key":"447_CR61","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/1538-7445.AM2018-2162","volume":"78","author":"R Li","year":"2018","unstructured":"Li R, et al. Abstract 2162: comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis. Cancer Res. 2018;78(13Supplement):2162\u20132162.","journal-title":"Cancer Res"},{"issue":"2","key":"447_CR62","doi-asserted-by":"publisher","first-page":"166941","DOI":"10.1016\/j.bbadis.2023.166941","volume":"1870","author":"ZR Kang","year":"2024","unstructured":"Kang ZR, et al. Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development. Biochim Biophys Acta Mol Basis Dis. 2024;1870(2):166941.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"447_CR63","doi-asserted-by":"crossref","unstructured":"Lee SJ et al. hsa-miR-CHA2, a novel MicroRNA, exhibits anticancer effects by suppressing Cyclin E1 in human non-small cell lung cancer cells. Biochimica et biophysica acta (BBA) - Molecular basis of disease. 2024;1870(6):167250.","DOI":"10.1016\/j.bbadis.2024.167250"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00447-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00447-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00447-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T06:05:38Z","timestamp":1748066738000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00447-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00447-y","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Xi\u2019an International Medical Center Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}